Vitamin D receptor gene polymorphisms and male breast cancer risk in Turkish population

Journal of B.U.ON.

Volumn 16, Issue 4, 2011, Pages 640-645

  Kizildag, Sefa ^a   Gulsu, E ^a   Bagci, O ^a   Yuksel, E ^a   Canda, T ^b  

^a Doha Eylul University   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Male breast cancer; Polymorphisms; RFLP; Vitamin D receptor

Indexed keywords

ESTROGEN RECEPTOR; GENOMIC DNA; PROGESTERONE RECEPTOR; VITAMIN D RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; MALE BREAST; MALE BREAST CANCER; POLYMERASE CHAIN REACTION; POPULATION RISK; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC);

ADULT; AGED; BREAST NEOPLASMS, MALE; CASE-CONTROL STUDIES; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RETROSPECTIVE STUDIES; TURKEY;

EID: 84855469305     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Perkins GH, Middleton LP. Breast cancer in men. BMJ 2003; 327: 239-240. (Pubitemid 36951588)
2. Firat D, Hayran M. Cancer statistics in Turkey and in the world (1st Edn). Ankara: iz Matbaacilik, 1995, pp 1-77.
3. Colston K, Berger U, Coombes RC. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1989; 333: 188-191. (Pubitemid 19038805)
4. Kizildag S, Ates H, Kizildag S. Treatment of K562 cells with 1,25-dihydroxyvitamin D(3) induces distinct alterations in the expression of apoptosis-related genes BCL2, BAX, BCL(XL), and p21. Ann Hematol 2010; 1: 1-7.
5. Ingraham BA, Bragdon B, Nohe A. Molecular basis of the potential of vitamin D to prevent cancer. Curr Med Res Opin 2008; 24: 139-149. (Pubitemid 351160247)
6. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene 2004; 338: 143-156. (Pubitemid 39094759)
7. Sillanpaa P, Hirvonen A, Kataja V et al. Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. Pharmacogenetics 2004; 14: 239-245. (Pubitemid 38530515)
8. Curran JE, Vaughan T, Lea RA, Weinstein SR, Morrison NA, Griffiths LR. Association of a vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer 1999; 83: 723-726.
9. McCullough ML, Stevens VL, Diver WR et al. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res 2007; 9: R1-7.
10. Colin EM, Weel AE, Uitterlinden AG et al. Consequences of vitamin D receptor gene polymorphisms for growth inhibition of cultured human peripheral blood mononuclear cells by 1, 25-dihydroxyvitamin D3. Clin Endocrinol 2000; 52: 211-216. (Pubitemid 30108268)
11. Chen WY, Bertone-Johnson ER, Hunter D J et al. Associations between polymorphisms in the vitamin D receptor and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2005; 14: 2335-2339. (Pubitemid 41437833)
12. Bretherton-Watt D, Given-Wilson R, Mansi JL, Thomas V, Carter N, Colston KW. Vitamin D receptor gene polymorphisms are associated with breast cancer risk in a UK Caucasian population. Br J Cancer 2001; 85: 171-175. (Pubitemid 32695735)
13. Bland KI, Menck HR, Scott-Conner CE, Morrow M, Winchester DJ, Winchester DP. The national cancer data base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 1998; 83: 1262-1273. (Pubitemid 28419082)
14. Rayson D, Erlichman C, Suman VJ, Roche PC, Wold LE, Ingle JN. Molecular markers in male breast carcinoma. Cancer 1998; 83: 1947-1955. (Pubitemid 28503726)
15. Scott-Conner CE, Jochimsen PR, Menck HR, Winchester DJ. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery 1999; 126: 775-780.
16. Cutuli B, Lacroze M, Dilhuydy JM, Veiten M, De Lafontan B, Marchal C. Male breast cancer: results of the treatment and prognostic factors in 397 cases. Eur J Cancer 1995; 31A: 1960-1964. (Pubitemid 26023085)
17. de Perrot M, Deleaval J, Robert J, Spiliopoulos A. Thirty year experience of surgery for breast carcinoma in men. Eur J Surg 2000; 166: 929-931. (Pubitemid 32002436)
18. Shoker BS, Jarvis C, Sibson DR, Walker C, Sloane JP. Oestrogen receptor expression in the normal and pre-cancerous breast J Pathol 1999; 188: 237-244. (Pubitemid 29317764)
19. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P. Generic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1998; 62: 676-689. (Pubitemid 28164626)
20. Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 1996; 13: 123-125. (Pubitemid 126528243)
21. Abbas S, Nieters A, Linseisen J et al. Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res 2008; 2: R311-11.
22. Anurupa C, Ashwani KM, Abha S et al. Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians. Cancer Detect Prevent 2009; 32: 386-394.
23. Trabert B, Malone KE, Dalin JR et al. Vitamin D receptor polymorphisms and breast cancer risk in a large population-based case-control study of Caucasian and African-American women. Breast Cancer Res 2007; 6: R84.
24. Slattery ML. Vitamin D Receptor Gene (VDR) Associations with Cancer. Nutr Rev 2007; 65: 102-104.
25. Ingles SA, Haile RW, Henderson BE et al. Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: implications for association studies. Cancer Epidem Biomark Prev 1997; 6: 93-98. (Pubitemid 27069201)
26. Woodson K, Ratnasinghe D, Bhat NK et al. Prevalence of disease-related DNA polymorphisms among participants in a large cancer prevention trial. Eur JCanc Prev 1999; 8: 441-447. (Pubitemid 30048074)